| Application number | Title of the application | Filing Date | Status |
|---|
| 07/808979 | NOVEL COMPOUNDS | Dec 16, 1991 | Abandoned |
| 07/808537 | NOVEL TISSUE PLASMINOGEN ACTIVATOR VARIANTS | Dec 15, 1991 | Abandoned |
| 07/808366 | NOVEL TISSUE PLASMINOGEN ACTIVATOR VARIANTS | Dec 15, 1991 | Abandoned |
Array
(
[id] => 2951689
[patent_doc_number] => 05242819
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1993-09-07
[patent_title] => 'DNA molecules encoding hybrid proteins of tissue plasminogen activator and urokinase'
[patent_app_type] => 1
[patent_app_number] => 7/808936
[patent_app_country] => US
[patent_app_date] => 1991-12-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 38
[patent_figures_cnt] => 40
[patent_no_of_words] => 37012
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 422
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/242/05242819.pdf
[firstpage_image] =>[orig_patent_app_number] => 808936
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/808936 | DNA molecules encoding hybrid proteins of tissue plasminogen activator and urokinase | Dec 12, 1991 | Issued |
Array
(
[id] => 2967126
[patent_doc_number] => 05258298
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1993-11-02
[patent_title] => 'Deletion and glycosylation mutant of human tissue plasminogen activator'
[patent_app_type] => 1
[patent_app_number] => 7/805415
[patent_app_country] => US
[patent_app_date] => 1991-12-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 32
[patent_figures_cnt] => 32
[patent_no_of_words] => 12166
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 59
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/258/05258298.pdf
[firstpage_image] =>[orig_patent_app_number] => 805415
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/805415 | Deletion and glycosylation mutant of human tissue plasminogen activator | Dec 9, 1991 | Issued |
Array
(
[id] => 3724783
[patent_doc_number] => 05700677
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-12-23
[patent_title] => 'Protein analogues of tissue plasminogen activator'
[patent_app_type] => 1
[patent_app_number] => 7/799769
[patent_app_country] => US
[patent_app_date] => 1991-11-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 10105
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/700/05700677.pdf
[firstpage_image] =>[orig_patent_app_number] => 799769
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/799769 | Protein analogues of tissue plasminogen activator | Nov 26, 1991 | Issued |
Array
(
[id] => 3774675
[patent_doc_number] => 05756686
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-05-26
[patent_title] => 'Peptides derived from endothelial cell growth factor'
[patent_app_type] => 1
[patent_app_number] => 8/192757
[patent_app_country] => US
[patent_app_date] => 1991-11-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 36
[patent_no_of_words] => 12719
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/756/05756686.pdf
[firstpage_image] =>[orig_patent_app_number] => 192757
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/192757 | Peptides derived from endothelial cell growth factor | Nov 14, 1991 | Issued |
Array
(
[id] => 3026226
[patent_doc_number] => 05348867
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1994-09-20
[patent_title] => 'Expression of proteins on bacterial surface'
[patent_app_type] => 1
[patent_app_number] => 7/794731
[patent_app_country] => US
[patent_app_date] => 1991-11-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 11
[patent_no_of_words] => 11651
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 110
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/348/05348867.pdf
[firstpage_image] =>[orig_patent_app_number] => 794731
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/794731 | Expression of proteins on bacterial surface | Nov 14, 1991 | Issued |
| 07/791927 | DNA ENCODING A GLYCINE TRANSPORTER AND USES THEREOF | Nov 11, 1991 | Abandoned |
| 07/787496 | RECOMBINANT BONE MORPHOGENETIC PROTEIN HETERODIMERS, COMPOSITIONS AND MEHTODS OF USE | Nov 3, 1991 | Abandoned |
| 07/777121 | SECRETED GLYCOPROTEIN | Oct 15, 1991 | Abandoned |
| 07/769626 | ASTROCYTE-SPECIFIC TRANSCRIPTION OF HUMAN GENES | Oct 3, 1991 | Abandoned |
Array
(
[id] => 2945057
[patent_doc_number] => 05262170
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1993-11-16
[patent_title] => 'Tissue plasminogen activator having zymogenic or fibrin specific properties and substituted at amino acid positions 296-299, DNA molecules encoding them, vectors, and host cells'
[patent_app_type] => 1
[patent_app_number] => 7/770510
[patent_app_country] => US
[patent_app_date] => 1991-10-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 9
[patent_no_of_words] => 19585
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/262/05262170.pdf
[firstpage_image] =>[orig_patent_app_number] => 770510
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/770510 | Tissue plasminogen activator having zymogenic or fibrin specific properties and substituted at amino acid positions 296-299, DNA molecules encoding them, vectors, and host cells | Oct 2, 1991 | Issued |
Array
(
[id] => 3453405
[patent_doc_number] => 05378613
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1995-01-03
[patent_title] => 'Method for increased expression of low molecular weight recombinant polypeptides'
[patent_app_type] => 1
[patent_app_number] => 7/764655
[patent_app_country] => US
[patent_app_date] => 1991-09-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 11196
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 140
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/378/05378613.pdf
[firstpage_image] =>[orig_patent_app_number] => 764655
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/764655 | Method for increased expression of low molecular weight recombinant polypeptides | Sep 23, 1991 | Issued |
Array
(
[id] => 3418100
[patent_doc_number] => 05453491
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1995-09-26
[patent_title] => 'Murine interleukin-5 receptor'
[patent_app_type] => 1
[patent_app_number] => 7/757390
[patent_app_country] => US
[patent_app_date] => 1991-09-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 15
[patent_no_of_words] => 8848
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/453/05453491.pdf
[firstpage_image] =>[orig_patent_app_number] => 757390
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/757390 | Murine interleukin-5 receptor | Sep 9, 1991 | Issued |
Array
(
[id] => 3620448
[patent_doc_number] => 05593857
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-01-14
[patent_title] => 'Production of homogeneous truncated CNTF'
[patent_app_type] => 1
[patent_app_number] => 7/749446
[patent_app_country] => US
[patent_app_date] => 1991-08-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 5896
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 47
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/593/05593857.pdf
[firstpage_image] =>[orig_patent_app_number] => 749446
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/749446 | Production of homogeneous truncated CNTF | Aug 22, 1991 | Issued |
| 07/746651 | MUTEINS OF EPIDERMAL GROWTH FACTOR EXHIBITING ENHANCED BINDING AT LOW PH | Aug 15, 1991 | Abandoned |
Array
(
[id] => 2964847
[patent_doc_number] => 05258180
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1993-11-02
[patent_title] => 'Tissue plasminogen activator having fibrin specific properties and deletion of amino acids 466-970, compositions and methods of treatment'
[patent_app_type] => 1
[patent_app_number] => 7/744614
[patent_app_country] => US
[patent_app_date] => 1991-08-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 10800
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/258/05258180.pdf
[firstpage_image] =>[orig_patent_app_number] => 744614
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/744614 | Tissue plasminogen activator having fibrin specific properties and deletion of amino acids 466-970, compositions and methods of treatment | Aug 12, 1991 | Issued |
Array
(
[id] => 2854889
[patent_doc_number] => 05149533
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1992-09-22
[patent_title] => 'Modified t-PA with kringle-/replaced by another kringle'
[patent_app_type] => 1
[patent_app_number] => 7/747452
[patent_app_country] => US
[patent_app_date] => 1991-08-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 30
[patent_figures_cnt] => 30
[patent_no_of_words] => 13072
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 103
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/149/05149533.pdf
[firstpage_image] =>[orig_patent_app_number] => 747452
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/747452 | Modified t-PA with kringle-/replaced by another kringle | Aug 11, 1991 | Issued |
| 07/720771 | PDGF-A, PDGF-AA, PDGF-AB, PREPARATION PROCESS AND PHARMACEUTICALS CONTAINING THEM | Aug 6, 1991 | Abandoned |